Molecule Structure

Scientific Name

Etomidate

Description of the Drug

Etomidate is a short-acting intravenous anesthetic indicated for the induction of anesthesia and supplementation of subpotent anesthesia during short operative procedures.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00292

Brand Name(s)

Amidate, Etomidate

Company Owner(s)

Luitpold Pharmaceuticals Inc, Hikma Farmaceutica Portugal Sa, Mylan Laboratories Ltd, Par Sterile Products Llc, Caplin Steriles Ltd, Rising Pharma Holding Inc, Gland Pharma Ltd, Hospira Inc, Eugia Pharma Specialities Ltd, Emcure Pharmaceuticals Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
GABA-A receptor; anion channel PROTEIN COMPLEX GROUP POSITIVE MODULATOR CHEMBL2093872

Unichem Links

SureChEMBL SCHEMBL39487
Human Metabolome Database HMDB0014437
DrugBank DB00292
PubChem: Thomson Pharma 14749667
PubChem 667484
Mcule MCULE-1817647743
LINCS LSM-37126
Nikkaji J17.549H
PDBe V8D
BindingDB 50125935
DrugCentral 1109
ChemicalBook CB4113298
Guide to Pharmacology 5463
rxnorm ETOMIDATE AMIDATE
PubChem: Drugs of the Future 12013395
ChEBI 4910
ZINC ZINC000000001408